Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 8
1978 9
1979 9
1980 8
1981 5
1982 5
1983 6
1984 6
1985 8
1986 13
1987 15
1988 15
1989 26
1990 23
1991 27
1992 26
1993 37
1994 18
1995 28
1996 30
1997 28
1998 51
1999 34
2000 31
2001 39
2002 38
2003 37
2004 37
2005 54
2006 56
2007 45
2008 38
2009 50
2010 47
2011 43
2012 40
2013 45
2014 46
2015 52
2016 46
2017 53
2018 37
2019 39
2020 33
2021 16
Text availability
Article attribute
Article type
Publication date

Search Results

1,282 results
Results by year
Filters applied: . Clear all
Page 1
Chronic kidney disease.
Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ. Romagnani P, et al. Among authors: remuzzi g. Nat Rev Dis Primers. 2017 Nov 23;3:17088. doi: 10.1038/nrdp.2017.88. Nat Rev Dis Primers. 2017. PMID: 29168475 Review.
C3 glomerulopathy - understanding a rare complement-driven renal disease.
Smith RJH, Appel GB, Blom AM, Cook HT, D'Agati VD, Fakhouri F, Fremeaux-Bacchi V, Józsi M, Kavanagh D, Lambris JD, Noris M, Pickering MC, Remuzzi G, de Córdoba SR, Sethi S, Van der Vlag J, Zipfel PF, Nester CM. Smith RJH, et al. Among authors: remuzzi g. Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2. Nat Rev Nephrol. 2019. PMID: 30692664 Free PMC article. Review.
COVID-19 and Italy: what next?
Remuzzi A, Remuzzi G. Remuzzi A, et al. Among authors: remuzzi g. Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13. Lancet. 2020. PMID: 32178769 Free PMC article. Review.
Overview of complement activation and regulation.
Noris M, Remuzzi G. Noris M, et al. Among authors: remuzzi g. Semin Nephrol. 2013 Nov;33(6):479-92. doi: 10.1016/j.semnephrol.2013.08.001. Semin Nephrol. 2013. PMID: 24161035 Free PMC article. Review.
Estimated GFR: time for a critical appraisal.
Porrini E, Ruggenenti P, Luis-Lima S, Carrara F, Jiménez A, de Vries APJ, Torres A, Gaspari F, Remuzzi G. Porrini E, et al. Among authors: remuzzi g. Nat Rev Nephrol. 2019 Mar;15(3):177-190. doi: 10.1038/s41581-018-0080-9. Nat Rev Nephrol. 2019. PMID: 30518813 Review.
Treatment of membranous nephropathy: time for a paradigm shift.
Ruggenenti P, Fervenza FC, Remuzzi G. Ruggenenti P, et al. Among authors: remuzzi g. Nat Rev Nephrol. 2017 Sep;13(9):563-579. doi: 10.1038/nrneph.2017.92. Epub 2017 Jul 3. Nat Rev Nephrol. 2017. PMID: 28669992 Review.
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C. Legendre CM, et al. Among authors: remuzzi g. N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981. N Engl J Med. 2013. PMID: 23738544 Free article. Clinical Trial.
1,282 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page